Found: 26
Select item for more details and to access through your institution.
Real‐world feasibility of short‐term, unsupervised home spirometry in CF.
- Published in:
- Pediatric Pulmonology, 2022, v. 57, n. 12, p. 3129, doi. 10.1002/ppul.26147
- By:
- Publication type:
- Article
Attitudes towards involving children in decision‐making surrounding lung transplantation.
- Published in:
- Pediatric Pulmonology, 2021, v. 56, n. 6, p. 1534, doi. 10.1002/ppul.25321
- By:
- Publication type:
- Article
M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. e749, doi. 10.1634/theoncologist.2018-0596
- By:
- Publication type:
- Article
Interpretation of Results from Under‐accruing Studies.
- Published in:
- Oncologist, 2018, v. 23, n. 7, p. 755, doi. 10.1634/theoncologist.2018-0145
- By:
- Publication type:
- Article
Pragmatic approaches to address expansion cohort design.
- Published in:
- 2018
- By:
- Publication type:
- editorial
Activity of erlotinib when dosed below the maximum tolerated dose for EGFR-mutant lung cancer: Implications for targeted therapy development.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 15, p. 2570, doi. 10.1002/cncr.29397
- By:
- Publication type:
- Article
Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond RECIST progression.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Oncogenic mutations in cervical cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 21, p. 3776, doi. 10.1002/cncr.28288
- By:
- Publication type:
- Article
Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 21, p. 3761, doi. 10.1002/cncr.28290
- By:
- Publication type:
- Article
Comparison of Pneumotachometer and Portable Digital Turbine Spirometry for Field-Based Assessment: An Air Quality, Environment, and Respiratory Outcomes in Bronchopulmonary Dysplasia Study.
- Published in:
- Pediatric Allergy, Immunology & Pulmonology, 2023, v. 36, n. 3, p. 115, doi. 10.1089/ped.2023.0046
- By:
- Publication type:
- Article
Evaluation of statistical designs in phase I expansion cohorts: the dana-farber/harvard cancer center experience.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Evaluation of Statistical Designs in Phase I Expansion Cohorts: The Dana-Farber/Harvard Cancer Center Experience.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju163
- By:
- Publication type:
- Article
A Proportional Hazards Cure Model for the Analysis of Time to Event with Frequently Unidentifiable Causes.
- Published in:
- Biometrics, 2007, v. 63, n. 4, p. 1237, doi. 10.1111/j.1541-0420.2007.00811.x
- By:
- Publication type:
- Article
The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 4, p. 452, doi. 10.1111/j.1365-2141.2010.08524.x
- By:
- Publication type:
- Article
Peer-to-Peer Social Media Communication About Dietary Supplements Used for Weight Loss and Sports Performance Among Military Personnel: Pilot Content Analysis of 11 Years of Posts on Reddit.
- Published in:
- JMIR Formative Research, 2021, v. 5, n. 10, p. 1, doi. 10.2196/28957
- By:
- Publication type:
- Article
Cytologic‐histologic correlation of programmed death‐ligand 1 immunohistochemistry in lung carcinomas.
- Published in:
- Cancer Cytopathology, 2018, v. 126, n. 4, p. 253, doi. 10.1002/cncy.21973
- By:
- Publication type:
- Article
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.
- Published in:
- Nature Medicine, 2012, v. 18, n. 7, p. 1118, doi. 10.1038/nm.2819
- By:
- Publication type:
- Article
Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: Report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
- Published in:
- Pediatric Blood & Cancer, 2011, v. 57, n. 3, p. 492, doi. 10.1002/pbc.23060
- By:
- Publication type:
- Article
Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.
- Published in:
- Pediatric Blood & Cancer, 2009, v. 53, n. 2, p. 162, doi. 10.1002/pbc.22076
- By:
- Publication type:
- Article
Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7511, doi. 10.1002/cam4.3416
- By:
- Publication type:
- Article
Efficacy and Safety of High-dose Cholecalciferol in Patients With Inflammatory Bowel Disease Receiving Infliximab.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501).
- Published in:
- 2014
- By:
- Publication type:
- journal article